secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARDELYX, INC. (ARDX)
CIK:        0001437402
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001628280-24-044547
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardelyx Q3 revenue $98.2M; IBSRELA $40.6M, XPHOZAH $51.5M; net loss $0.8M
-------------------------------------------------------------------------

- IBSRELA Q3 net sales $40.6M (+15% QoQ); full-year guidance set at $145-150M.
- XPHOZAH Q3 net sales $51.5M (+39% QoQ); strong launch continues.
- Total revenue $98.2M (up 74% YoY); net loss $0.8M vs net income $6.6M in Q3 2023.
- Cash $190.4M at Sep 30; drew $49.7M from SLR loan (SOFR+4.02%) in October.
- Appointed Eric Foster as CCO in August; CMS Part D change for XPHOZAH cited as 2025 headwind.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1437402/000162828024044547/0001628280-24-044547-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1437402/000162828024044547/ardx-20241031.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-044547

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer